Parkinson’s disease is a common neurodegenerative disease characterized by the presence of bradykinesia, rigidity, resting tremor and postural instability. The purpose of this clinical study is to determine the panchakarma therapy an effective and safe treatment option that can enhance the speed and degree of recovery, minimal risk associated with panchakarma and high patient acceptance in preference to other methods of treatment of Parkinson’s disease. Hence, the study was performed with some herbal drugs with low toxicity profile and their effects were evaluated with the help of clinical study. Total 10 patients diagnosed as Parkinson’s disease of any socio-economic status, age group of 41-70 years and irrespective of sex of all ethnic origins were randomly selected. The trial was designed as a thirty days Panchakarma therapy (Karma Basti). The UPDRS (Unified Parkinson’s Disease Rating Score) scale was applied to the measure the degree of improvement and conclusion was drawn that Panchakarma therapy is highly significant in cases of Parkinson’s disease. The Panchakarma therapy provided a significant effect on the symptom bradykinesia (64.51%), rigidity (69.56%), tremors (64.51%) and postural stability (61.53%) of Parkinson’s disease. Most of the patients, that is 07 patients (70%) were marked relieved, followed by 02 patients (20%) were moderately improved and 01 patient (10%) was completely cured after completion of the treatment. The clinical study illustrates that significant gains in improvement of balance, gait, functional movement made by an individual in relatively short periods of time. Patients with Parkinson’s disease may often turn to Panchakarma therapy with the hope of improving their quality of life.
